Navigation Links
Pharmacyclics Receives Non-Approvable Letter from the FDA for Xcytrin for the Treatment of Lung Cancer Brain Metastases
Date:12/21/2007

SUNNYVALE, Calif., Dec. 21 /PRNewswire-FirstCall/ -- Pharmacyclics, Inc. (Nasdaq: PCYC) today announced that it has received a non-approvable letter from the U.S. Food and Drug Administration (FDA) for the company's new drug application (NDA) for Xcytrin(R) (motexafin gadolinium) Injection for the treatment of non-small cell lung cancer (NSCLC) patients with brain metastases. The NDA for use of Xcytrin in combination with whole brain radiation therapy (WBRT) was filed with the FDA in April 2007.

According to the National Cancer Institute, over 200,000 patients will be diagnosed with lung cancer this year in the U.S. Lung cancer is the most common cause of brain metastases, which are estimated to occur in up to 50% of lung cancer patients.

Pharmacyclics recently completed patient enrollment in three Phase 2 trials evaluating Xcytrin in patients with advanced relapsed NSCLC. These multi-center trials will evaluate Xcytrin as a single agent, in combination with Taxotere(R) (docetaxel), and in combination with Alimta(R) (pemetrexed). Data from these trials is expected in the first half of 2008.

"We are disappointed that brain metastases patients with limited options and serious neurologic problems will not have access to Xcytrin, which we believe has shown important clinical activity in this indication," said Richard A. Miller, M.D., president and chief executive officer of Pharmacyclics. "We continue to believe that Xcytrin is a novel active cancer drug and we will seek a corporate partner to help support future development. In the meantime, we are also advancing our expanding and versatile pipeline of product candidates."

Xcytrin's novel mechanism enables it to selectively concentrate in tumors and induce apoptos
'/>"/>

SOURCE Pharmacyclics, Inc.
Copyright©2007 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine news :

1. Lake Elsinore Family Caregiver Receives Free Power Wheelchair From The SCOOTER Store
2. DaVita Receives Civil Complaint
3. Ranbaxy Receives Tentative Approval to Manufacture and Market Galantamine Tablets on an Exclusive Basis
4. Watson Receives First FDA Approval for Manufacturing Product at Its Goa, India Facility
5. Edwards Lifesciences Receives CE Mark for Edwards SAPIEN Transcatheter Heart Valve
6. PainCare Receives $14.4 Million in Cash From Completed Sale of South Florida Ambulatory Surgery Centers
7. UT Southwesterns obesity research receives $22 million NIH Roadmap grant
8. Temple Emergency Medicine receives $1.8M to find best MRSA treatment
9. Prime Therapeutics Receives TIPPS Certification
10. Bioniche Receives $2 Million Government Grant For Market Development Related to its E. coli O157:H7 Cattle Vaccine
11. UCLA receives $22.5 million to explore the fundamental biology of mental disorders
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/5/2015)... INTEGRATED Healthcare Strategies, a trusted ... in its 2015 Children’s Hospitals Executive Compensation Survey. ... positions, and the survey results are exclusive to ... data on 60 executive and director level positions, ... 7 subsidiary children’s hospitals. Additionally, it provided a ...
(Date:3/5/2015)... Leading nutritional supplement provider Metabolic ... Festival and Arnold Fitness EXPO in Columbus, ... host a display booth featuring free samples of its ... highly-popular, class-leading fat burner Synedrex. The company will also ... utilize its top-of-the-line supplements and miniature action figures of ...
(Date:3/5/2015)... Nutrition Leaders, a premier purveyor of health, ... reformulated Millennium 500 Creatine to its customers. Available from ... grade creatine supplement that has been micronized to more ... with overall strength gains in users. , Creatine is ... energy source in the body and helps fuel muscle ...
(Date:3/5/2015)... Jordan Valley Medical Center is now ... option for sudden cardiac arrest. When a patient wears ... detect any life-threatening abnormalities. If an abnormal heart rhythm ... delivering a treatment shock to restore normal rhythm to ... Valley Medical Center and the Heart and Lung Institute ...
(Date:3/5/2015)... USA (PRWEB) March 05, 2015 Kevin ... possible by the grips of drug addiction. The siblings ... support their habits, and to seek refuge during the ... using drugs, without consideration for his outward appearance, hygiene, ... addictive substances. CNY Central reported on Feb. ...
Breaking Medicine News(10 mins):Health News:Participation Is Now Open For INTEGRATED Healthcare Strategies 2015 Children’s Hospitals Executive Compensation Survey 2Health News:Metabolic Nutrition Exhibiting at 2015 Arnold Sports Festival and Fitness EXPO This Week 2Health News:Nutrition Leaders Offers Reformulated Millennium 500 German Grade Creatine 2Health News:New Technology Behind LifeVest® Wearable Defibrillator Saves the Life of Utah Man in Cardiac Arrest 2Health News:New Technology Behind LifeVest® Wearable Defibrillator Saves the Life of Utah Man in Cardiac Arrest 3Health News:The Homeless’ Unaddressed Drug Addiction Continues to Spiral Out of Control, Harbor Village Detox Stresses Treatment for the Homeless 2Health News:The Homeless’ Unaddressed Drug Addiction Continues to Spiral Out of Control, Harbor Village Detox Stresses Treatment for the Homeless 3
... Feb. 8 "Healing" has become a buzzword in ... book, Healing (Hawk Press, 2010), healer David Elliott ... natural state of balance and harmony that is called love."  The ... says Elliott, "but it,s true - until we love ourselves, we ...
... Ohio A new national study suggests that preschool-aged children ... they regularly engage in one or more of three specific ... and limiting their weekday television viewing time. In a ... 4-year-olds living in homes with all three routines had an ...
... has found that women with medium or low levels ... after being diagnosed with the precancerous breast condition, ductal ... Cancer , a peer-reviewed journal of the American ... hardship may benefit from psychosocial interventions that are designed ...
... ... is a 12-month MBA program focused on executive leadership. Delivered in a blended learning format ... Ken Blanchard EMBA attracts student leaders from all over the US. , ... Phoenix, AZ (PRWEB) February 5, 2010 -- The ...
... may increase the risk of developing asthma after the menopause, ... the journal Thorax . The authors base their ... use of HRT and development of asthma symptoms every two ... taking part in the French E3N study, which includes almost ...
... ... to capture the authentic heartbeat of NY Jets Quarterback Mark Sanchez for a CBS Cares ... stethoscope is a favorite in broadcasting - this may be the biggest audience to hear ... ...
Cached Medicine News:Health News:New Book, 'Healing,' Claims 'What's Ailing the U.S. is What's Ailing Us All' - Offers Healing Self-Love 2Health News:New Book, 'Healing,' Claims 'What's Ailing the U.S. is What's Ailing Us All' - Offers Healing Self-Love 3Health News:New Book, 'Healing,' Claims 'What's Ailing the U.S. is What's Ailing Us All' - Offers Healing Self-Love 4Health News:New Book, 'Healing,' Claims 'What's Ailing the U.S. is What's Ailing Us All' - Offers Healing Self-Love 5Health News:Family meals, adequate sleep and limited TV may lower childhood obesity 2Health News:Family meals, adequate sleep and limited TV may lower childhood obesity 3Health News:Family meals, adequate sleep and limited TV may lower childhood obesity 4Health News:Financial hardship contributes to diagnosis anxiety 2Health News:The Ken Blanchard Executive MBA Program at Grand Canyon University is a Unique Cohort System Creating Unusual Bonds - Begins in February 2Health News:The Ken Blanchard Executive MBA Program at Grand Canyon University is a Unique Cohort System Creating Unusual Bonds - Begins in February 3Health News:Estrogen-only HRT may increase risk of asthma after menopause 2Health News:Superbowl Heartbeat from Thinklabs Electronic Stethoscope 2
(Date:3/5/2015)... , March 5, 2015 Soligenix, Inc. ... biopharmaceutical company committed to developing products that address unmet ... biodefense, announced today that its President and Chief Executive ... a corporate presentation at the 27 th Annual ... , on Tuesday, March 10, 2015 at 1:00 PM ...
(Date:3/5/2015)... March 5, 2015 Hitachi ... generation of OASIS *    at ECR 2015 ... power will set a benchmark for patient-centric care. The ... prevent delays whilst optimizing workflow management and costs. OASIS ... and safety for imaging in Neurology, Orthopaedics, Paediatrics, Oncology, ...
(Date:3/5/2015)... COPENHAGEN, Denmark , March 5, 2015 /PRNewswire/ ... company that applies its innovative TransCon technology to ... will present two posters at the ENDO 2015 ... Center.  The posters will be presented on Thursday, ... that is being held from 1:00pm-3:00pm PST, and ...
Breaking Medicine Technology:Soligenix to Present at the 27th Annual ROTH Conference 2Soligenix to Present at the 27th Annual ROTH Conference 3Hitachi Medical Systems Europe Launches the New Generation of OASIS*- The World's Most Powerful Open High-Field 1.2T MRI - A New Level in Patient-Centric Care 2Hitachi Medical Systems Europe Launches the New Generation of OASIS*- The World's Most Powerful Open High-Field 1.2T MRI - A New Level in Patient-Centric Care 3Ascendis Pharma to Present at ENDO 2015 2
... Dendreon Corporation (Nasdaq: DNDN ) today announced its ... million aggregate principal amount of convertible senior notes due January ... Securities Act of 1933, as amended (the "Securities Act").  The ... stock (the "Common Stock") or a combination of cash and ...
... Jan. 13, 2011 Puritan Medical Products Company, ... and applicators in North America, has announced the ... flocked products. The new HydraFlock ™ and UltraFlock™ ... extremely rapid release performance. Both products ...
Cached Medicine Technology:Dendreon Announces Offering of $500 Million Convertible Senior Notes Due 2016 2Dendreon Announces Offering of $500 Million Convertible Senior Notes Due 2016 3Dendreon Announces Offering of $500 Million Convertible Senior Notes Due 2016 4Puritan Medical Products Introduces New Patent Pending Flocked Swab Technology 2
The ExcaliburPlus PC is the most powerful isolated ESU with 10,000 V PTP in spray coag....
This unit is the finest standalone handswitch bipolar unit available....
Standard bipolar coagulator...
...
Medicine Products: